Holen Sie sich die Stockscreener-App
1.42
2.16%
0.03
Handel nachbörslich:
1.42
Schlusskurs vom Vortag:
$1.39
Offen:
$1.36
24-Stunden-Volumen:
51,316
Relative Volume:
0.05
Marktkapitalisierung:
$1.42M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.29M
KGV:
-0.2731
EPS:
-5.2
Netto-Cashflow:
$-9.42M
1W Leistung:
-2.74%
1M Leistung:
+5.19%
6M Leistung:
-41.32%
1J Leistung:
-63.02%
1-Tages-Spanne:
$1.35
$1.4654
1-Wochen-Bereich:
$1.35
$1.525
52-Wochen-Spanne:
$1.20
$6.18
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Company Profile
Firmenname
Scinai Immunotherapeutics Ltd Adr
Sektor
Branche
Telefon
972-8-9302529
Adresse
JERUSALEM BIOPARK, 2ND FLOOR, JERUSALEM
Vergleichen Sie SCNI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SCNI
Scinai Immunotherapeutics Ltd Adr
|
1.42 | 4.81M | 0 | -9.29M | -9.42M | -5.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.63 | 109.29B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.00 | 62.13B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.69 | 61.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.18 | 51.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.03 | 34.68B | 4.56B | -176.77M | 225.30M | -1.7177 |
Scinai Immunotherapeutics Ltd Adr Aktie (SCNI) Neueste Nachrichten
Scinai receives $246,000 grant to expand biotech manufacturing By Investing.com - Investing.com South Africa
Scinai receives $246,000 grant to expand biotech manufacturing - Investing.com
Scinai Immunotherapeutics (NASDAQ: SCNI) Reports First-Half 2025 Results, Strengthened Cash Position - Barchart.com
Scinai Reports Six-Month 2025 Financial Results Highlighting Continued CDMO Revenue Growth and Strengthened Balance Sheet - Barchart.com
Scinai Immunotherapeutics (NASDAQ:SCNI) Trading Down 3.8% – Here’s What Happened - Defense World
Scinai Immunotherapeutics Ltd ADR (SCNI) Stock: Uncovering 52-Week Market Trends - investchronicle.com
Scinai Immunotherapeutics (NASDAQ: SCNI) Publishes Peer-Reviewed Data Supporting PC111 as Potential Disease Modifier - Barchart.com
Scinai Immunotherapeutics stock soars on promising skin disease drug data By Investing.com - Investing.com South Africa
Scinai Immunotherapeutics stock soars on promising skin disease drug data - Investing.com Australia
Scinai’s PC111 antibody shows promise for pemphigus treatment By Investing.com - Investing.com Canada
Scinai’s PC111 antibody shows promise for pemphigus treatment - Investing.com India
ICICI Bank Ltd. ADR (IBN) Stock: Navigating a Year of Stock Volatility - investchronicle.com
Scinai Announces New Peer-Reviewed Publication Supporting PC111 as a Disease-Modifying Therapy for Pemphigus and SJS/TEN - Benzinga
Augusta Gold (TSE:G) Shares Pass Below Two Hundred Day Moving Average – Time to Sell? - Defense World
Scinai Immunotherapeutics Faces Financial Challenges, Seeks Growth - TipRanks
Scinai Immunotherapeutics Reports Strong CDMO Growth - TipRanks
Scinai Immunotherapeutics (NASDAQ: SCNI) Expands CDMO Operations with New U.S. Subsidiary - Barchart.com
Scinai Immunotherapeutics (NASDAQ: SCNI) Reports $4.8M Net Gain in 2024, Driven by Loan-to-Equity Conversion - Barchart.com
Scinai Immunotherapeutics (NASDAQ: SCNI) to Host Webinar on PC111 Antibody for Rare Skin Disorders - Barchart.com
Military Breakthrough: BrainChip and Raytheon Land $1.8M Air Force Deal for Next-Gen Radar - Stock Titan
Scinai Immunotherapeutics (NASDAQ: SCNI) Enters Option Agreement to Acquire Italian Biotech Pincell - The Globe and Mail
Bayerische Motoren Werke ADR (OP: BMWYY - FinancialContent
Scinai regains Nasdaq compliance, eyes EIB loan conversion - Investing.com
Scinai Immunotherapeutics enacts reverse split to meet Nasdaq rules - Investing.com
Scinai Immunotherapeutics (NASDAQ: SCNI) Announces Participation at BIO-Europe Munich 2023 - Barchart.com
Finanzdaten der Scinai Immunotherapeutics Ltd Adr-Aktie (SCNI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.03%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):